nimustine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujioka, K; Funabiki, T; Goto, H; Goto, S; Hanzawa, N; Ikuta, K; Izaki, S; Kai, S; Matsuda, M; Okuda, K; Sasaki, H; Sekiguchi, H; Sumita, H; Takahashi, H; Watanabe, Y; Yokota, S | 1 |
Kikuchi, H; Moritake, K; Paine, JT; Shima, N; Yamabe, H; Yamasaki, T | 1 |
Hattori, M; Kuga, T; Makishima, M; Sampi, K; Yanagawa, S | 1 |
Endo, N; Imai, S; Shimamoto, Y | 1 |
Oguro, M; Sakai, C; Takagi, T | 1 |
Amemiya, Y; Kanou, Y; Kitagawa, S; Komatsu, N; Motoyoshi, K; Mutoh, Y; Ohta, M; Suda, K; Takagi, S; Tsuboyama, A | 1 |
6 other study(ies) available for nimustine and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Long-term follow-up of busulfan, etoposide, and nimustine hydrochloride (ACNU) or melphalan as conditioning regimens for childhood acute leukemia and lymphoma.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Nimustine; Recurrence; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Chemotherapeutic effects of intra-arterial administration of ACNU in primary intracerebral non-Hodgkin's lymphoma.
Topics: Adult; Aged; Brain Neoplasms; Female; Humans; Infusions, Intra-Arterial; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nimustine; Tomography, X-Ray Computed; Treatment Outcome | 1993 |
[Intensive 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3- nitrosourea hydrochloride (ACNU) and cryopreserved autologous bone marrow transplantation].
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; Cryopreservation; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasms; Nimustine; Remission Induction; Transplantation, Autologous | 1993 |
[Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Nimustine; Prednisone; Remission Induction; Vincristine | 1992 |
[BH-AC.nitrosourea-therapy for refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Recurrence | 1992 |
[Autologous bone marrow transplantation using the AAABC regimen in patients with malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Nimustine; Nitrosourea Compounds; Whole-Body Irradiation | 1986 |